Microneedle Drug Delivery Systems Market is poised to reach US$1.2 Bn by the end of 2030 | CAGR of 6.6% | The Europe region is expected to reach US$ 380 million by 2030

Emerging applications of Microneedle Drug Delivery Systems are expected to fuel their demand over the next decade. According to a recent report published by Future Market Insights (FMI), the global microneedle drug delivery systems market will grow at a CAGR of 6.6% between 2020 and 2030. The market is witnessing surging demand in the field of pharmacy and cosmetics.

The rising incidence of diseases such as cancer, diabetes, migraine, and others and the need to accurately administer medications are driving the market. Additionally, the demand for minimally invasive and painless treatment methods is expected to bode well for the market.

The report uncovers hidden growth opportunities. It also highlights potential threats to the market players. Some of the key takeaways from the report are highlighted below.

Key Takeaways from the Report

Solid microneedles are expected to lead the market during forecast period of 2020-2030 among product type
Hospitals are the leading end users of microneedle drug delivery systems, with specialty clinics gaining popularity.
Specialty clinics are expected to grow at an accelerated rate as one of the key end users of microneedle drug delivery systems
North America is the largest market for microneedle drug delivery systems. Along with Europe, it is expected to cover more than 70% of the market by end of 2030.
East Asia is expected to be the fastest growing regional market during the next decade.
“Companies operating in the market are leaving no stone unturned to introduce innovations. Some have even tied up with leading solutions provider to commercialize their innovations once approved. This is expected to pave way for the market’s growth in the near future” said a lead Analyst at FMI.

Request For Sample Copy of Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2750

Covid 19 Restricting Pace of Growth

The onset of pandemic has disturbed the entire business ecosystem. With productions coming to a halt and supply chains disrupted due to lack of transport, manufacturers of microneedle drug delivery systems are impacted in a big way.

Also, because of several restrictions by governments like social distancing, doctors and practitioners are choosing to avoid any surgical treatments which are not absolutely and immediately necessary.

Furthermore, cosmetic field which is another major user of microneedle drug delivery systems is also impacted as almost all treatments under their umbrella are considered to be not urgent.

Who is winning?

The key market players in microneedle drug delivery systems market include the 3M Company, Becton, Dickinson and Company, Zosano Pharma Corporation, Raphas co. ltd., Nanopass Tech, Corium International, Inc., Valeritas, Inc., Nitto Denko Corporation, Microdermics, Inc., TheraJect Inc., Vaxxas Pty Ltd., Endoderma Ltd., QuadMedicine, SNvia Co., Ltd., Small Lab and AdminMed Nano BioSciences LLC

Consolidating their positions through mergers, acquisitions and new product launches, global microneedle drug delivery systems market players rely heavily on new product innovation and differentiation for gaining an edge over their competitors.

Any Queries, Ask Us @ https://www.futuremarketinsights.com/ask-question/rep-gb-2750

The market is poised to grow during the forecast period owing to the increasing cases of diseases and needle phobia among patients. However, changing regulatory dynamics are expected to affect the growth of microneedle drug delivery systems market in the future.

For instance, Zosano Pharma’s clinical trial of zolmitriptan with microneedle drug delivery system was stopped by U. S. Food and Drug Administration because inconsistencies were found in the drug delivery.

To Know More about Microneedle Drug Delivery Systems Market:

Future Market Insights (FMI) brings the comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global microneedle drug delivery systems market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on microneedle drug delivery systems market on the basis of product type such as solid microneedles, hollow microneedles and dissolving microneedles. Based on end-user such as hospitals, ambulatory centers, specialty clinics, academic institutes and research institutes across seven major regions

Request For Report TOC: https://www.futuremarketinsights.com/reports/microneedle-drug-delivery-systems-market/table-of-content

Key questions answered in report

What is the expected growth rate for microneedle drug delivery systems market?
The microneedle drug delivery systems market is predicted to grow at a CAGR of 6.6 % by the end of the forecast period 2020-2030.

Which is the largest market for microneedle drug delivery systems based on region?
North America is the largest market for microneedle drug delivery systems with Europe close behind.

Which are the top companies influencing the microneedle drug delivery systems market?
Some of the key players in microneedle drug delivery systems market are 3M Company, Becton, Dickinson and Company, Zosano Pharma Corporation, Raphas co. ltd., Nanopass Tech, Corium International, Inc., Valeritas, Inc., Nitto Denko Corporation.

What are the major applications of microneedle drug delivery systems?
Types of microneedle drug delivery systems are Solid Microneedles, Hollow Microneedles and Dissolving Microneedles

Which is the leading end-use industry in microneedle drug delivery systems market?
Hospitals are the leading end users of microneedle drug delivery systems.

Buy Industry Research Report: https://www.futuremarketinsights.com/checkout/2750

Contact

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For Sales Enquiries: sales@futuremarketinsights.com

For Media Enquiries: press@futuremarketinsights.com

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

This release was published on openPR.